You're looking at Less Wrong's discussion board. This includes all posts, including those that haven't been promoted to the front page yet. For more information, see About Less Wrong.

lsparrish comments on [LINK] Open Source Software Developer with Terminal Illness Hopes to Opt Out of Death - Less Wrong Discussion

17 Post author: lsparrish 13 February 2013 05:57AM

You are viewing a comment permalink. View the original post to see all comments and the full post content.

Article Navigation

Comments (18)
Tags: cryonics charity

Comments (18)

You are viewing a single comment's thread. Show more comments above.

Comment author: lsparrish 13 February 2013 05:11:21PM 6 points [-]

As far as I know, in over 50 years of existence, cryonics didn't develop or improve any technique for medicine to use.

For one, Hextend, a blood plasma volume expander used in conventional surgery, was developed by cryonicists at Trans Time, Inc while experimenting with hypothermia.

It's hard to understand cryonics in any meaningful way if you don't have wide swaths of regular science. Osmosis, ice formation, glass formation, toxicity mechanisms, chilling injury, apoptosis, blood pressure, ischemia, perfusion impairment... I will be wikifying this in the near future.

Comment author: V_V 13 February 2013 08:34:29PM 0 points [-]

For one, Hextend, a blood plasma volume expander used in conventional surgery, was developed by cryonicists at Trans Time, Inc while experimenting with hypothermia.

Can you provide more information, please?

The product you mention seems to have been developed by BioTime, a biomedical company.
The only relationship between BioTime and Trans Time (a now defunct for-profit cryonics company) that I've been able to find on Google was that Trans Time owned some stocks of BioTime:

http://www.cryonet.org/cgi-bin/dsp.cgi?msg=6399

Comment author: lsparrish 13 February 2013 09:15:33PM 3 points [-]

This is what I'm going on:

Unless you are a long-time cryonicist or a surgeon, you may not have heard of BioTime before. This company, recently profiled for its innovative stem cell research in Life Extension Magazine, is best known for producing the blood-volume expander Hextend, which was initially developed by Trans Time, an early cryonics company performing ultra-profound hypothermia research. Realizing the potential for Hextend’s conventional medical applications, BioTime was formed and, as they say, the rest is history.

http://www.evidencebasedcryonics.org/2008/10/12/biotimes-quest-to-defeat-aging/

Comment author: V_V 13 February 2013 10:29:54PM 0 points [-]

Thanks

Powered by Reddit Powered by Reddit